Healthcare stocks were falling Friday morning after noted anti-vaccine crusader Robert F. Kennedy Jr. was announced as ...

By Samuel Indyk and Ludwig Burger (Reuters) -Shares in global vaccine makers fell sharply on Friday after U.S.

Shares of vaccine makers fell as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, ...

Shares of vaccine makers plunged after President-elect Donald Trump nominated Robert F. Kennedy Jr. to run the Department of ...

President-elect Donald Trump said he is tapping Robert F. Kennedy Jr., to run the Department of Health and Human Services, a ...

Drug manufacturers saw their stock prices fall on Friday after vaccine skeptic Robert F. Kennedy Jr. was announced as Trump's ...

GSK and Sanofi, the world’s two biggest vaccine makers by sales, both fell more than 3.5 per cent, while the nomination also hit the pharmaceutical sector more broadly, with a basket of European ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...